Related Experiment Video
Updated: Jun 8, 2026

Cryosectioning and Immunostaining Mouse Inner Ear Tissue: From Embryonic to Adult Stages
Published on: April 11, 2025
Histopathologic changes of the ear in canine models of mucopolysaccharidosis types I and VII
J Hordeaux1, J Deniaud, I Bemelmans
1Institut National de la Recherche Agronomique, Nantes, France.
Abstract:
Mucopolysaccharidosis (MPS) types I and VII are inborn errors of metabolism caused by mutation of enzymes involved in glycosaminoglycan catabolism, which leads to intralysosomal accumulation of glycosaminoglycans. In children, severe forms of MPS I and VII are characterized by somatic and neurologic manifestations, including a poorly understood hearing loss. The purpose of this study is to describe the age-related histopathologic changes of the ear in spontaneous canine models of MPS I and VII. Pathologic changes in the ear were assessed in MPS I and VII dogs ranging from 1.6 to 9.3 months of age. Paraffin-embedded sections of the whole ear and Epon-embedded semithin sections of the cochlea were examined. The following lesions were blindly scored in the middle and inner ear: inflammation, cells vacuolization, thickening of osseous and membranous structures, perivascular vacuolated macrophages infiltration, and bone resorption. All dogs had lysosomal storage within cells of tympanic membrane, ossicles, tympanic bone and mucosa, cochlear bone, spiral ligament, limbus, and stria vascularis. The MPS I dogs mainly had progressive cochlear lesions. The MPS VII dogs had severe and early middle ear lesions, including chronic otitis media and bone resorption. The MPS I dog only partially recapitulates the pathology seen in humans; specifically, the dog model lacks inflammatory middle ear disease. In contrast, the MPS VII dog has severe inflammatory middle ear disease similar to that reported in the human. In conclusion, the canine MPS VII model appears to be a good model to study MPS VII-related deafness.
Insights
Canine models of Mucopolysaccharidosis (MPS) types I and VII reveal distinct ear pathologies. The MPS VII dog model closely mimics human hearing loss, showing severe middle ear disease and bone resorption.
Area of Science:
- Genetics and Metabolic Disorders
- Otolaryngology
- Comparative Pathology
Background:
- Mucopolysaccharidosis (MPS) types I and VII are genetic metabolic disorders.
- These conditions result from enzyme deficiencies in glycosaminoglycan breakdown, leading to cellular accumulation.
- Hearing loss is a significant, yet poorly understood, manifestation in severe MPS cases.
Purpose of the Study:
- To characterize age-related histopathologic changes in the ears of canine models with MPS I and VII.
- To compare the utility of MPS I and VII canine models for studying hearing loss.
Main Methods:
- Examination of paraffin-embedded whole ear sections and Epon-embedded cochlear sections from MPS I and VII dogs (1.6–9.3 months old).
- Blind scoring of lesions including inflammation, vacuolization, tissue thickening, macrophage infiltration, and bone resorption in the middle and inner ear.
- Assessment of lysosomal storage in various ear structures.
Main Results:
- All MPS dogs exhibited lysosomal storage in tympanic membrane, ossicles, cochlear bone, and stria vascularis.
- MPS I dogs showed progressive cochlear lesions.
- MPS VII dogs presented with severe, early middle ear lesions, chronic otitis media, and bone resorption, mirroring human pathology.
Conclusions:
- The canine MPS VII model demonstrates significant middle ear pathology, including inflammation and bone resorption, similar to human MPS VII.
- The MPS VII canine model is a valuable tool for investigating MPS VII-related deafness.
- The MPS I canine model partially recapitulates human pathology but lacks inflammatory middle ear disease.

